2015 |
R43 |
CA199152 |
PAR-13-327 |
EASTBURN, DENNIS J |
MISSION BIO, INC. |
MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING |
Complete |
2016 |
R43 |
CA203675 |
PAR-13-327 |
KLUGE, JONATHAN AUGUST |
VAXESS TECHNOLOGIES, INC. |
SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS |
Complete |
2015 |
R43 |
CA199211 |
PAR-13-327 |
GAU, VINCENT JEN-JR |
GENEFLUIDICS, INC. |
PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE |
Complete |
2016 |
R43 |
CA203629 |
PAR-13-327 |
GUNDERSON, KEVIN L |
ENCODIA, INC. |
Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer |
Complete |
2016 |
R43 |
CA203647 |
PAR-13-327 |
LIM, MARK |
AMBERGEN, INC |
Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays |
Complete |
2016 |
R43 |
CA203681 |
PAR-13-327 |
KING, JEFFREY S |
VIROGENOMICS BIODEVELOPMENT, INC. |
Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia |
Complete |
2016 |
R44 |
CA199194 |
PAR-13-327 |
KARSTEN, STANISLAV |
NEUROINDX INC. |
Automated Platform for Fixed Tissue Microdissection |
Complete |
2016 |
R44 |
CA187852 |
PAR-13-327 |
JOHNSON, DAVID SCOTT |
GIGAGEN, INC. |
Next-Generation Antibody Discovery and Development Technology |
Complete |
2014 |
R43 |
CA187852 |
PAR-13-327 |
JOHNSON, DAVID SCOTT |
GIGAGEN, INC. |
B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY |
Complete |
2014 |
R43 |
CA188154 |
PAR-13-327 |
FELLMANN, CHRISTOF |
MIRIMUS, INC. |
RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO |
Complete |
2014 |
R44 |
CA161965 |
PAR-13-327 |
LIM, MARK |
AMBERGEN, INC |
GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS |
Complete |
2017 |
R43 |
CA214386 |
PAR-13-327 |
PEYTAVI, REGIS |
BLUENOVO BIOSYSTEMS, INC. |
Detection of Methylation and Translocation Events by Novel Sequencing Technology |
Complete |
2017 |
R44 |
CA188154 |
PAR-13-327 |
PREMSRIRUT, PREM KHOVABUTR |
MIRIMUS, INC. |
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research |
Complete |
2015 |
R43 |
CA187787 |
PAR-13-327 |
SELIGMANN, BRUCE E. |
BIOSPYDER TECHNOLOGIES, INC. |
IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE |
Complete |
2015 |
R43 |
CA192674 |
PAR-13-327 |
LELENTAL, MARK |
CATASSAYS |
NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION |
Complete |
2015 |
R43 |
CA193087 |
PAR-13-327 |
MANDECKI, WLODEK |
PHARMASEQ, INC. |
SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT |
Complete |
2015 |
R43 |
CA193096 |
PAR-13-327 |
JIANG, LI |
A'AS, INC. |
KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA |
Complete |
2015 |
R43 |
CA193101 |
PAR-13-327 |
TRAN, HIEP T |
ABZYME THERAPEUTICS, LLC |
HYBRIDOMA FREE MULTIPLEX APPROACH FOR ACCELERATING MOUSE MONOCLONAL ANTIBODY GENERATION |
Complete |
2015 |
R43 |
CA193128 |
PAR-13-327 |
MESSMER, BRADLEY T |
ABREOS BIOSCIENCES, INC. |
MULTIPLEXED DENANO PROTEIN ASSAY AND QUANTITATION: SEQUENCING BASED PROTEOMICS |
Complete |
2015 |
R43 |
CA193134 |
PAR-13-327 |
NEVO, EREZ |
ROBIN MEDICAL, INC. |
COMBINED OPTICAL AND MR MICROSCOPY SYSTEM FOR THIN TISSUE HISTOPATHOLOGY ANALYSIS |
Complete |
2020 |
R43 |
CA243757 |
PAR-18-303 |
ERVIN, ERIC |
ELECTRONIC BIOSCIENCES, INC. |
N6-Methyl-2-O-Methyladenosine Sequencing |
Active |
2020 |
R44 |
CA247353 |
PAR-18-303 |
FRIEDA, KIRSTEN |
SPATIAL GENOMICS, INC. |
Spatial and single cell analysis of tumor microenvironment by seqFISH+ |
Active |
2020 |
R43 |
CA250805 |
PAR-18-303 |
WANG, SHA |
VIVID TECHNOLOGIES |
New specific and rapid assay for in situ apoptosis labeling for cancer studies |
Active |
2021 |
R44 |
CA261523 |
PAR-18-303 |
HUNG, PAUL JU-SUNG |
COMBINATI, INC. |
Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring |
Active |
2020 |
R44 |
CA243990 |
PAR-18-303 |
GURARD-LEVIN, ZACHARY |
SAMDI TECH, INC. |
Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities |
Active |
2020 |
R44 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues |
Active |
2020 |
R43 |
CA250885 |
PAR-18-303 |
REDER, NICHOLAS |
LIGHTSPEED MICROSCOPY, INC. |
Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies |
Active |
2018 |
R43 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues |
Active |
2018 |
R43 |
CA236101 |
PAR-18-303 |
LEE, LY JAMES |
NANOMATERIAL INNOVATION, LTD |
Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis |
Complete |
2018 |
R43 |
CA236142 |
PAR-18-303 |
SCHOETTLE, LOUIS |
GEMNEO BIOSCIENCE, INC. |
Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes |
Complete |
2020 |
R43 |
CA236167 |
PAR-18-303 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations |
Active |
2019 |
R43 |
CA236103 |
PAR-18-303 |
KHODAVERDIAN, VARANDT Y. |
NUPROBE USA, INC. |
Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing |
Complete |
2019 |
R43 |
CA236167 |
PAR-18-303 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations |
NCE |
2020 |
R44 |
CA250672 |
PAR-18-303 |
WINTERS, IAN PAUL |
D2G ONCOLOGY, INC. |
Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform |
Active |
2019 |
R43 |
CA236177 |
PAR-18-303 |
KASOJI, SANDEEP |
TRIANGLE BIOTECHNOLOGY, INC. |
SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples |
Complete |
2019 |
R43 |
CA239967 |
PAR-18-303 |
BROWN, MARK T |
CLAREMONT BIOSOLUTIONS, LLC |
Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis |
Complete |
1999 |
R41 |
CA081825 |
PAR-98-066 |
MACH, ROBERT H |
ANASAZI BIOMEDICAL RESEARCH, INC. |
SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION |
Complete |
1999 |
R43 |
CA081835 |
PAR-98-066 |
MOSTERT, MICHAEL J |
ECHELON BIOSCIENCES, INC. |
PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS |
Complete |
1999 |
R43 |
CA081860 |
PAR-98-066 |
CHANG, HWAI W |
STRATAGENE |
GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES |
Complete |
1999 |
R43 |
CA081870 |
PAR-98-066 |
MILLER, JEFFREY E. |
IVS TECHNOLOGIES, LLC |
NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS |
Complete |
2000 |
R41 |
CA083369 |
PAR-98-066 |
SWENBERG, JAMES A |
ENO RIVER LABS, LLC |
ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION |
Complete |
2000 |
R41 |
CA084688 |
PAR-98-066 |
SKIPPER, PAUL L |
NEWTON SCIENTIFIC, INC. |
TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS |
Complete |
1999 |
R43 |
CA081890 |
PAR-98-066 |
NERI, BRUCE P |
THIRD WAVE TECHNOLOGIES, INC. |
SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION |
Complete |
2000 |
R41 |
CA084693 |
PAR-98-066 |
LIFSHITZ, NADIA |
BIOPHOTONICS CORPORATION |
MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA |
Complete |
1999 |
R43 |
CA081891 |
PAR-98-066 |
WEAVER, DANIEL C |
GENOMICA CORPORATION |
ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY |
Complete |
1999 |
R43 |
CA081903 |
PAR-98-066 |
TS'O, PAUL O. P. |
CCC DIAGNOSTICS, LLC |
ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD |
Complete |
2000 |
R43 |
CA084678 |
PAR-98-066 |
BAMDAD, CYNTHIA C. |
MINERVA BIOTECHNOLOGIES CORPORATION |
RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS |
Complete |
1999 |
R43 |
CA081949 |
PAR-98-066 |
OLINER, JONATHAN D |
AFFYMETRIX, INC. |
REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS |
Complete |
2000 |
R43 |
CA084679 |
PAR-98-066 |
PERLIN, MARK W |
CYBERGENETICS CORPORATION |
AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY |
Complete |
1999 |
R43 |
CA081951 |
PAR-98-066 |
XANTHOPOULOS, KLEANTHIS G |
AURORA BIOSCIENCES CORPORATION |
ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS |
Complete |